Skip Nav Destination
Issue Highlights
- Review: novel molecular insights in EMZL
- FLT3-ITD MRD levels and relapse risk in AML
- Combination of CD33-targeting BsAbs and STING agonist for the treatment of AML
- GATA2 expression and chemotherapy resistance in AML
- Babesia infection exacerbates SCD red cell phenotypes
- Transcriptional signatures in mouse and human chronic GVHD
- How I Treat: AML relapse after allogeneic HCT
Latest in Blood
Catharina Conrad; Mélia Magnen; Jessica Tsui; Harrison Wismer; Mohammad Naser; Urmila Venkataramani; Bushra Samad; Simon J. Cleary; Longhui Qiu; Jennifer J. Tian; Marco De Giovanni; Nicole Mende; Andrew D. Leavitt; Emmanuelle Passegué; Elisa Laurenti; Alexis J. Combes; Mark R. Looney
Lara Wahlster; Lucy A Godley; Jason X Cheng; Michael W Drazer; Christopher R. Reilly; Geraldine S Pinkus; Jared H Rowe; Nina Weichert-Leahey; Robert Grant Rowe; Lev Gorfinkel; Karyn Jean Brundige; Franziska Wachter; Luana Miria Messa; Alan D Michelson; Alan B. Cantor; Akiko Shimamura; Jacob R Bledsoe
Mark J. Levis; Mehdi Hamadani; Brent R. Logan; Richard J. Jones; Anurag K. Singh; Mark R. Litzow; John R. Wingard; Esperanza B. Papadopoulos; Alexander E. Perl; Robert J. Soiffer; Celalettin Ustun; Masumi Ueda Oshima; Geoffrey L. Uy; Edmund K. Waller; Sumithira Vasu; Melhem Solh; Asmita Mishra; Lori S. Muffly; Hee-Je Kim; Matthias Stelljes; Yuho Najima; Masahiro Onozawa; Kirsty Thomson; Arnon Nagler; Andrew H. Wei; Guido Marcucci; Caroline Chen; Nahla Hasabou; Matt Rosales; Jason Hill; Stanley C. Gill; Rishita Nuthethi; Denise King; Adam Mendizabal; Steven M. Devine; Mary M. Horowitz; Yi-Bin Chen
Advertisement intended for health care professionals